Inflammatory Markers after Switching to a Dual Drug Regimen in HIV-Infected Subjects: A Two-Year Follow-Up
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14050927
Abstract: Objective: Immunadapt is a study evaluating the impact of combination antiretroviral treatment (cART) simplification on immune activation. We previously showed that switching to dual therapies could be associated six months later with macrophage activation. Followup… read more here.
Keywords: switching dual; inflammatory markers; markers switching; dual drug ... See more keywords